The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...

The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...

The company is at a pivotal point following the killing of Brian Thompson, who headed the UnitedHealthcare unit, and there was a public outcry about insurance denials. That prompted Andrew Witty, the ...

The National Association of Chain Drug Stores is praising the Federal Trade Commission's (FTC) unanimous, 5-0, vote on Monday to release the second interim staff report on the FTC's study of big ...

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

UnitedHealth shares a quarterly report for the first time since the death of insurance unit leader Brian Thompson. A look at ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...